Agarwal Arjun Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
1
Insider Sells Sum
$16,313.50

Insider Activity of Agarwal Arjun

According to the SEC Form 4 filings, Agarwal Arjun, being in a position of

  1. Senior Vice President, Finance at Oruka Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 62143 shares for $5.08M,
    over all time since 2026-03-16, has bought 0 shares, and sold 62143 shares for $5.08M.

Biography of Agarwal Arjun

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $5,084,27510100

Comparison of Insiders on Amount of Buys and Sells

2026-10-12SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
9,999
0.016%
$80.60$805,889+0.37%
2026-09-15SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
560
0.001%
$95.71$53,598-8.69%
2026-09-11SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
9,459
0.015%
$92.23$872,413-8.66%
2026-08-13SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
10,000
0.0164%
$106.66$1.07M-15.23%
2026-07-13SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
9,999
0.026%
$84.63$846,180+9.14%
2026-06-22SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
1,587
0.0047%
$80.95$128,468+7.55%
2026-06-15SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
395
0.0011%
$69.69$27,528+33.08%
2026-06-12SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
9,459
0.0252%
$69.72$659,508+31.11%
2026-05-18SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
10,290
0.0262%
$59.07$607,806+51.3%
2026-03-16SaleOruka Therapeutics, Inc.
ORKA
Senior Vice President, Finance
395
0.001%
$41.30$16,314+96.67%
Total: 10
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.